POP-OUT | CLOSE
MyPDB Login - Username: Password:

About: MyPDB stores and automatically runs your favorite queries. Email alerts are sent when matching structures are found.

    MyPDB Login
MyPDB: Login | Register
RCSB PDB Protein Data Bank | Home A Member of the wwPDB

An Information Portal to Biological Macromolecular Structures

As of Tuesday Feb 09, 2010 at 4 PM PST there are 63271 Structures RSS Feed for the Latest Released Structures Help | Latest Released  |  PDB Statistics Help | PDB Statistics
RCSB PDB Protein Data Bank | Home

Print Options: BW Safe Color Safe Print




URL:
 
 
HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL-BASED C2-SYMMETRIC INHIBITOR
 
 
DOI:10.2210/pdb1w5x/pdb
1W5X
 
Primary Citation
spinning wheel
 
 
  •  
    Move Section Molecular Description Hide
    Classification: Hydrolase/hydrolase Inhibitor
    Structure Weight: 24781.11
     
    Molecule:POL POLYPROTEIN
    Polymer:1Type:polypeptide(L)Length:110
    Chains:A, B
    EC#:3.4.23.16 Go to IUBMB EC entry  
    Fragment:RESIDUES 58-167
     
     
  •  
    Move Section Source Hide
    Polymer: 1
    Scientific Name: Human immunodeficiency virus Go to NCBI Taxonomy entry Common Name: Hiv-1 Expression System: Escherichia coli  
     
     
  •  
    Move Section Related PDB Entries Hide
    Id Details
    1AJV  HIV-1 PROTEASE IN COMPLEX WITH THE CYCLIC SULFAMIDE INHIBITOR AHA006 
    1AJX  HIV-1 PROTEASE IN COMPLEX WITH THE CYCLIC UREA INHIBITOR AHA001 
    1AXA  ACTIVE-SITE MOBILITY IN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE AS DEMONSTRATED BY CRYSTAL STRUCTURE OF A28S MUTANT 
    1BQM  HIV-1 RT/HBY 097 
    1BQN  TYR 188 LEU HIV-1 RT/HBY 097 
    1D4H  HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA435 
    1D4I  HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA425 
    1D4J  HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR MSL370 
    1DLO  HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 
    1DW6  STRUCTURAL AND KINETIC ANALYSIS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE 
    1EBK  STRUCTURAL AND KINETIC ANALYSIS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE 
    1EBW  HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA322 
    1EBY  HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA369 
    1EBZ  HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA388 
    1EC0  HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA403 
    1EC1  HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA409 
    1EC2  HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA428 
    1EC3  HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR MSA367 
    1EET  HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR MSC204 
    1HBV  HIV-1 PROTEASE COMPLEXED WITH SB203238 
    1HEF  HIV-1 PROTEASE COMPLEXED WITH SKF 108738 ( HEF) 
    1HEG  HIV-1 PROTEASE COMPLEXED WITH SKF 107457 ( HEG) 
    1HIH  HIV-1 PROTEASE COMPLEXED WITH INHIBITOR CGP 53820 
    1HMV  HIV-1 REVERSE TRANSCRIPTASE 
    1HNI  HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE (HIV-1RT) MUTANT WITH CYS 280 REPLACED BY SER (C280S) 
    1HNV  HIV-1 REVERSE TRANSCRIPTASE (HIV-1 RT) MUTANT WITH CYS 280 REPLACED BY SER (C280S ) 
    1HOS  HIV-1 PROTEASE COMPLEX WITH SB204144 
    1HPS  HIV-1 PROTEASE COMPLEXED WITH SB206343 
    1HPZ  HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 
    1HQE  HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 
    1HQU  HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 
    1HRH  RIBONUCLEASE H DOMAIN OF HIV-1 REVERSE TRANSCRIPTASE 
    1HTE  HIV-1 PROTEASE COMPLEXED WITH GR123976 
    1HTF  HIV-1 PROTEASE COMPLEXED WITH GR126045 
    1HTG  HIV-1 PROTEASE COMPLEXED WITH GR137615 
    1HVK  HIV-1 PROTEASE COMPLEXED WITH THE INHIBITOR A76928 (S,S) 
    1HVP  HIV-1 PROTEASE COMPLEX WITH SUBSTRATE ( THEORETICAL MODEL) 
    1HVU  HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE COMPLEXED WITH A 33-BASE NUCLEOTIDE RIBONUCLEIC ACID PSEUDOKNOT 
    1HYS  CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEXWITH A POLYPURINE TRACT RNA:DNA 
    1IKV  K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITHEFIVARENZ 
    1IKW  WILD TYPE HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITHEFAVIRENZ 
    1IKX  K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITHTHE INHIBITOR PNU142721 
    1IKY  HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITORMSC194 
    1J5O  CRYSTAL STRUCTURE OF MET184ILE MUTANT OF HIV -1 REVERSETRANSCRIPTASE IN COMPLEX WITH DOUBLE STRANDED DNA TEMPLATE-PRIMER 
    1MER  HIV-1 MUTANT (I84V) PROTEASE COMPLEXED WITH DMP450 
    1MES  HIV-1 MUTANT (I84V) PROTEASE COMPLEXED WITH DMP323 
    1MET  HIV-1 MUTANT (V82F) PROTEASE COMPLEXED WITH DMP323 
    1MEU  HIV-1 MUTANT (V82F, I84V) PROTEASE COMPLEXED WITH DMP323 
    1N5Y  HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST-TRANSLOCATION AZTMP-TERMINATED DNA ( COMPLEX P) 
    1N6Q  HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO PRE-TRANSLOCATION AZTMP-TERMINATED DNA ( COMPLEX N) 
    1QE1  CRYSTAL STRUCTURE OF 3TC-RESISTANT M184I MUTANT OF HIV-1 REVERSE TRANSCRIPTASE 
    1QMC  C-TERMINAL DNA-BINDING DOMAIN OF HIV-1 INTEGRASE, NMR, 42 STRUCTURES 
    1R0A  CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COVALENTLYTETHERED TO DNA TEMPLATE -PRIMER SOLVED TO 2.8 ANGSTROMS 
    1RDH  HIV-1 REVERSE TRANSCRIPTASE (RIBONUCLEASE H DOMAIN) 
    1RTD  STRUCTURE OF A CATALYTIC COMPLEX OF HIV-1 REVERSE TRANSCRIPTASE: IMPLICATIONS FOR NUCLEOSIDE ANALOG DRUG RESISTANCE 
    1RVL  REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH ALPHA-APA (R89439) ( THEORETICAL MODEL) 
    1RVM  REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH HEPT (THEORETICAL MODEL) 
    1RVN  REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH PHENYL-ISOINDOLINONE ( THEORETICAL MODEL) 
    1RVO  REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH NEVIRAPINE (THEORETICAL MODEL) 
    1RVP  REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH THIAZOLOISOINDOLINONE ( THEORETICAL MODEL) 
    1RVQ  REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH TIBO (THEORETICAL MODEL) 
    1RVR  REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH IMIDAZODIPYRIDODIAZEPINE (UK -129,485) (THEORETICAL MODEL) 
    1S6P  CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R100943 
    1S6Q  CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX WITH JANSSEN- R147681 
    1S9E  CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX WITH JANSSEN- R129385 
    1S9G  CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX WITH JANSSEN- R120394. 
    1SBG  HIV-1 PROTEASE COMPLEXED WITH THE INHIBITOR SB203386 
    1SUQ  CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX WITH JANSSEN- R185545 
    1SV5  CRYSTAL STRUCTURE OF K103N MUTANT HIV-1 REVERSETRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R165335 
    1T03  HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TENOFOVIRTERMINATED TEMPLATE-PRIMER (COMPLEX P) 
    1T05  HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TEMPLATE-PRIMERWITH TENOFOVIR-DIPHOSPHATE BOUND AS THE INCOMINGNUCLEOTIDE SUBSTRATE 
    1TV6  HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH CP-94,707 
    1TVR  HIV-1 RT/9-CL TIBO 
    1UWB  TYR 181 CYS HIV-1 RT/8-CL TIBO 
    1W5V  HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL-BASED C2-SYMMETRIC INHIBITOR 
    1W5W  HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL-BASED C2-SYMMETRIC INHIBITOR 
    1W5Y  HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL-BASED C2-SYMMETRIC INHIBITOR 
    2HMI  HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH A DOUBLE-STRANDED DEOXYRIBONUCLEIC ACID AND FAB28 
    3HVT  REVERSE TRANSCRIPTASE 
    3TLH  STRUCTURAL STUDIES OF HIV AND FIV PROTEASES COMPLEXED WITHAN EFFICIENT INHIBITOR OF FIV PR 
     
     
  •  
    Move Section Ligand Chemical Component Hide
    Identifier Name Formula Interaction View Links
    BE5     (2R,3R,4R,5R)-2,5-BIS[(2,3-DIFLUOROBENZYL)OXY]- 3,4-DIHYDROXY-N,N'-BIS[(1S,2R)-2
    -HYDROXY- 2,3-DIHYDRO-1H-INDEN-1-YL]HEXANEDIAMIDE
    C38 H36 F4 N2 O8 3DLigand Explorer Link out to Ligand Expos:BE5 Link out to SuperLigands:BE5 Link out to SuperHapten:BE5
     
     
  •  
    Move Section Derived Data Hide
     
     
 
< Biological Assembly    Help